Tyrosine Hydroxylase Links Adrenergic Nerves to Triple-Negative Breast Cancer Therapy
Triple-negative breast cancer has long been regarded as one of the most difficult forms of breast cancer to treat. Unlike...
Rowan B. covers cancer and oncology, including tumor biology, screening, diagnostics, treatment research, clinical trials, and survivorship science.
Triple-negative breast cancer has long been regarded as one of the most difficult forms of breast cancer to treat. Unlike...
A major collection of late-breaking research from the 2026 MASCC/ISOO Annual Meeting has been published in Supportive Care in Cancer,...
Cancer is often described as an older person’s disease, but a qualitative study of young adults in the United States...
Cancer survivors who leave specialist oncology clinics for follow-up in primary care are not disappearing from the cancer system, according...
A new artificial intelligence model is opening a potential path toward more personalized treatment for patients whose lung cancer has...
Philadelphia—A large randomized clinical trial has found that stereotactic body radiation therapy (SBRT), an increasingly used form of highly focused...
Immune checkpoint inhibitors have transformed cancer treatment by releasing molecular brakes that otherwise restrain T cells, yet their benefits remain...
Cervical cancer may be driven in part by a molecular switch that scientists have only recently begun to understand: the...
Cancer therapy-induced thrombocytopenia, a potentially treatment-limiting fall in platelet numbers, is drawing renewed attention after a multicenter phase II trial...
A Simple Genetic Test Could Make Capecitabine Treatment Safer for Patients With Metastatic Breast Cancer A routine genetic test performed...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine